Trajan tips for business sustainability at AusMedtech 2016

Trajan tips for business sustainability at AusMedtech 2016

August 15, 2016

Trajan Scientific and Medical (Trajan) Chief Executive Officer Stephen Tomisich, delivered the opening plenary at AusMedtech 2016 in Adelaide from 10 - 11 May, discussing how to grow and sustain scientific and medical device companies.

Mr Tomisich's address covered three key pillars to Trajan's business sustainability; foundation, activity, and risk mitigation.

View the full plenary video below, or on Trajan's YouTube channel.

 

More information
www.ausmedtech.com.au

Media contact information
Tel: +44 (0) 1244 403 100
media@trajanscimed.com




Also in News

Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti

November 30, 2020

Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.

This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.

Read More

Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions

November 11, 2020

In celebration of International Pathology Day, Trajan Scientific and Medical (Trajan) is proud to announce a new partnership with ScyTek Laboratories (ScyTek) to deliver quality immunohistochemistry (IHC) solutions.

Read More

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More